Gross Margin As a result of non-cash biological asset accounting during the quarter, the adjusted gross margin was $0.1 million, as compared to $0 (nil) for the same quarter in the prior year when no sales were recorded, and an increase from a negative $0.2 million in the prior quarter (Q4 2016).